Results 151 to 160 of about 39,412 (236)

Avenciguat: a novel soluble guanylate cyclase activator that affects multiple cell types to inhibit IFN-1 signalling and fibrosis. [PDF]

Rheumatology (Oxford)
Kaufman J, Nabozny G, Tran-Manh C, Liebel C, Zhou X, Daley LA, Wang CT, Ebenezer DL, Delic D, Wohnhaas CT, Trinh-Minh T, Distler JHW.   +11 more
europepmc   +1 more source

Ameliorating diabetes-associated atherosclerosis and diabetic nephropathy through modulation of soluble guanylate cyclase. [PDF]

Front Cardiovasc Med, 2023
Sharma A, Choi J, Sim L, Dey A, Mohan M, Kantharidis P, Dietz L, Sandner P, de Haan JB.   +8 more
europepmc   +1 more source

Editorial: Ferid murad, at 80: A legacy of science, medicine, and mentorship [PDF]

, 2016
Atta-Ur-Rahman,
core   +1 more source

Based on the FDA Adverse Event Reporting System Database, a Study on Signal Mining of Adverse Events for Guanylate Cyclase-C Receptor Agonists. [PDF]

Hosp Pharm
Lei D, Guo C, Zhao S.
europepmc   +1 more source

Catalytic region mimetics in Na+/H+ exchanger regulatory factor 4 suppress guanylate cyclase 2C activity to regulate enterotoxin triggered diarrhea. [PDF]

J Biol Chem
Ramananda Y, Liyanage P, Huang Y, Porollo A, Hannig G, Naren AP, Arora K.   +6 more
europepmc   +1 more source

Allosteric Communication of the Dimerization and the Catalytic Domain in Photoreceptor Guanylate Cyclase. [PDF]

Biochemistry
Shahu MK, Schuhmann F, Wong SY, Solov'yov IA, Koch KW.   +4 more
europepmc   +1 more source

Soluble Guanylate Cyclase Stimulator, BAY41-8543: A Promising Approach for the Treatment of Chronic Heart Failure Caused by Pressure and Volume Overload. [PDF]

Pharmacol Res Perspect
Martišková A, Sýkora M, Andelová N, Ferko M, Gawrys O, Andelová K, Kala P, Červenka L, Szeiffová Bačová B.   +8 more
europepmc   +1 more source

Guanylate cyclase activity of TIR1/AFB auxin receptors in rapid auxin responses

, 2023
Qi L, Kwiatkowski M, Kulich I, Chen H, Gao Y, Yun P, Li L, Shabala S, Farmer EE, Jaworski K, Friml J.   +10 more
europepmc   +1 more source

Soluble Guanylate Cyclase [PDF]

, 2020
openaire   +1 more source

The soluble guanylate cyclase activator runcaciguat significantly improves albuminuria in patients with chronic kidney disease: a randomized placebo-controlled clinical trial. [PDF]

Nephrol Dial Transplant
Gansevoort RT, Wheeler DC, Debén FM, Speeckaert M, Thomas D, Berger M, Klein S, Friedrichs F, Paraschin K, Schmieder RE.   +9 more
europepmc   +1 more source